Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

In vivo association of E2F and DP family proteins.

http://www.ncbi.nlm.nih.gov/pubmed/7739537

The mammalian transcription factor E2F plays an important role in regulating the expression of genes that are required for passage through the cell cycle. This transcriptional activity is inhibited by association with the retinoblastoma tumor suppressor protein (pRB) or its relatives p107 and p103. The first cDNA from the E2F family to be cloned was designated E2F-1, and multiple E2F family members have now been identified. They bind to DNA as heterodimers, interacting with proteins known as DP. Here we demonstrate that DP is also a family of polypeptides with at least two members (hDP-1 and hDP-2). Both hDP-1 and hDP-2 bind to all E2F family members in vivo, and each complex is capable of activating transcription. However, the various E2F/DP complexes display strong differences in the ability to bind to either pRB or p107 in vivo, and the specificity of pRB or p107 binding is mediated by the E2F subunit.

Pubmed ID: 7739537 RIS Download

Mesh terms: Amino Acid Sequence | Animals | Base Sequence | Carrier Proteins | Cell Cycle Proteins | Cell Line | DNA | DNA, Complementary | DNA-Binding Proteins | Drosophila Proteins | E2F Transcription Factors | E2F1 Transcription Factor | Gene Expression | Humans | Mice | Molecular Sequence Data | Protein Binding | RNA, Messenger | Retinoblastoma-Binding Protein 1 | Trans-Activators | Transcription Factor DP1 | Transcription Factors | Transcriptional Activation

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.